Follow Us:

Articles & Resources

Home ResourcesPage 11

3 thoughts on “Significance of Equivalent Device

  1. Yes, the manufacturer can demonstrate device equivalence to an already marketed device of another manufacturer, provided a contract is in place between the two manufacturers, as the blogger has mentioned.

    As per the EU MDR, the clinical investigation can be exempted, if the demonstration of equivalency together with the clinical evaluation of the marketed device (performed as per the MDR), and clear evidence to the NB by the manufacturer would suffice and prove the conformity with relevant safety and performance requirements.

  2. Demonstration of equivalence to an already marketed device has always been a practical way to prove that a new device is safe and effective also further additional clinical investigations may not be required.

    As per EU MDR Annex XIV, Part A, In clinical evaluation technical, biological and clinical characteristics to be taken into account for demonstration of equivalence. In this case the manufacturer will have access to the data relating to the marketed device. Then, it will be easy to understand the technical documentation and decide the same will suffice or further clinical data is required to justify the claims of equivalence with regard to the safety and performance of the device.

  3. In addition to above mentioned points by experts, to get exemption from Clinical Investigation in absence of demonstration of equivalence and clinical data for clinical evaluation, preclinical data and PMCF data can be used to prove the safety and performance of the device under evaluation.

Leave a Reply